Skip to main navigation Skip to search Skip to main content

Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

  • A. M.M. de Vrankrijker*
  • , R. W. Brimicombe
  • , T. F.W. Wolfs
  • , H. G.M. Heijerman
  • , R. Van Mansfeld
  • , F. T. Van Berkhout
  • , R. J.L. Willems
  • , M. J.M. Bonten
  • , C. K. Van Der Ent
  • *Corresponding author for this work
  • Utrecht University
  • Haga Ziekenhuis
  • Utrecht University, Utrecht, Netherlands

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Studies suggest that infection with highly prevalent Pseudomonas aeruginosa clones in cystic fibrosis (CF) is associated with an unfavourable clinical outcome. We studied the clinical characteristics of patients infected with a recently described, highly prevalent P. aeruginosa clone (ST406) in two CF centres in The Netherlands. Multilocus sequence typing data were available for 219 patients, of whom 40 (18.3%) were infected with ST406 and 179 with other sequence types. ST406 infection was independently associated with age, having a sibling with ST406 infection and use of inhaled antibiotics, but not with unfavourable clinical outcome, suggesting that high transmissibility is not necessarily associated with high virulence.

Original languageEnglish
Pages (from-to)382-385
Number of pages4
JournalClinical microbiology and infection
Volume17
Issue number3
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clone
  • Cross-infection
  • Cystic fibrosis
  • MLST
  • Pseudomonas aeruginosa

Fingerprint

Dive into the research topics of 'Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients'. Together they form a unique fingerprint.

Cite this